Advancing potential treatment options for melanoma
Learn about Pfizer’s clinical research that is focused on melanoma, a form of skin cancer.
Despite recent advances in the treatment of melanoma, more options are needed. Pfizer is currently conducting a clinical trial that is looking at whether three study drugs are safe and effective when given together for melanoma that:
- is advanced or metastatic (spread to other parts of the body);
- has a certain type of abnormal gene called “BRAF”
About half of people with metastatic melanoma have the BRAF gene, which causes cancer cells to multiply out of control. Identifying whether a person with melanoma has the BRAF gene is an important way to identify an appropriate treatment.
If you or a loved one are considering taking part in a melanoma clinical trial, find more information below. With your participation, clinical research might help to identify better treatment options for people with melanoma.